Pharmacokinetics of Roflumilast and Its Active Metabolite Roflumilast N-Oxide in Healthy Chinese Subjects After Single and Multiple Oral Doses View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-06

AUTHORS

Qian Li, Yiya Wang, Lingye Liu, Pengcheng Ma, Li Ding

ABSTRACT

BACKGROUND AND OBJECTIVES: Roflumilast is a selective, oral phosphodiesterase 4 inhibitor approved for the treatment of severe chronic obstructive pulmonary disease. The aim of this study was to evaluate the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy Chinese subjects, and the effects of gender and food on their respective pharmacokinetic profiles. METHODS: 36 healthy Chinese subjects were recruited in a randomized, single-center, open-label, parallel group study and assigned to 0.25-, 0.375-, and 0.5-mg dose groups. The single-dose pharmacokinetic studies in fasting condition were carried out in all groups. Moreover, the food effect study and multiple-dose study were conducted in 0.375-mg dose group. Serial blood samples were collected over 168 h after dosing, and plasma concentrations of roflumilast and roflumilast N-oxide were determined using a validated LC-MS/MS method. RESULTS: After oral administration of single doses of 0.25, 0.375 and 0.5 mg of roflumilast under fasting condition, the mean AUC0-72h for roflumilast was 21.7 ± 8.3, 29.8 ± 8.3 and 54.2 ± 21.3 ng·h/mL, respectively. Meanwhile the mean AUC0-168h for roflumilast N-oxide was 290 ± 103, 385 ± 107 and 673 ± 245 ng·h/mL, respectively. In the steady state after the multi-dose administration, the exposure to roflumilast in the subjects increased 20-40 %, and the exposure to roflumilast N-oxide increased about 169 %, compared to the single-dose administration. No statistically significant effect of gender on the disposition of roflumilast and roflumilast N-oxide was observed. Food had no effect on systemic exposure to roflumilast and roflumilast N-oxide in the subjects, but delayed the T max of roflumilast by 0.9 h and reduced the C max of roflumilast by approximately 20 %. CONCLUSION: Based upon between-study comparison, peak and systemic exposure of roflumilast and roflumilast N-oxide were higher in Chinese than that in Caucasian subjects after oral administration of the same dose (i.e., 0.25 and 0.5 mg). It implies that the therapeutic dose for Chinese patients may be different from that for Caucasians, warranting further investigation. More... »

PAGES

371-381

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13318-016-0343-4

DOI

http://dx.doi.org/10.1007/s13318-016-0343-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1020443704

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27306372


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aminopyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Area Under Curve", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Asian Continental Ancestry Group", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chromatography, Liquid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclopropanes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Healthy Volunteers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphodiesterase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tandem Mass Spectrometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "China Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.254147.1", 
          "name": [
            "Department of Pharmaceutical Analysis, China Pharmaceutical University, 24 Tongjiaxiang, 210009, Nanjing, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Qian", 
        "id": "sg:person.0740757371.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740757371.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Nanjing Clinical Tech Laboratories Inc., 18 Zhilan Road, Jiangning District, 211000, Nanjing, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Yiya", 
        "id": "sg:person.015572713305.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015572713305.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "China Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.254147.1", 
          "name": [
            "Department of Pharmaceutical Analysis, China Pharmaceutical University, 24 Tongjiaxiang, 210009, Nanjing, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Lingye", 
        "id": "sg:person.01140701426.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140701426.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Chinese Academy of Medical Sciences Dermatology Hospital", 
          "id": "https://www.grid.ac/institutes/grid.477246.4", 
          "name": [
            "Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, 12 Jiangwangmiao Street, 210042, Nanjing, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ma", 
        "givenName": "Pengcheng", 
        "id": "sg:person.01353315753.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353315753.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "China Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.254147.1", 
          "name": [
            "Department of Pharmaceutical Analysis, China Pharmaceutical University, 24 Tongjiaxiang, 210009, Nanjing, People\u2019s Republic of China", 
            "Nanjing Clinical Tech Laboratories Inc., 18 Zhilan Road, Jiangning District, 211000, Nanjing, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ding", 
        "givenName": "Li", 
        "id": "sg:person.0627711653.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627711653.12"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1164/rccm.200612-1749oc", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000450293"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1067/mcp.2001.115447", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001959141", 
          "https://doi.org/10.1067/mcp.2001.115447"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.07-1131", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003811806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1067/mcp.2001.117703", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003973100", 
          "https://doi.org/10.1067/mcp.2001.117703"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.13-1252", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006208929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1476-5381.2011.01218.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025189857"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00216063", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030399080", 
          "https://doi.org/10.1007/bf00216063"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0091270006294529", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035843651"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3389/fphys.2015.00294", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038971699"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.2011.04076.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039517595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200746050-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042151859", 
          "https://doi.org/10.2165/00003088-200746050-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11536600-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044802363", 
          "https://doi.org/10.2165/11536600-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/11536600-000000000-00000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044802363", 
          "https://doi.org/10.2165/11536600-000000000-00000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2710.2000.00281.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047972899"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200746070-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048498102", 
          "https://doi.org/10.2165/00003088-200746070-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pupt.2010.03.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050658534"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-013-0089-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051435708", 
          "https://doi.org/10.1007/s40262-013-0089-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0091270004268128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051961362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5414/cp201556", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072834043"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0042-121903", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074194059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074786415", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074786416", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074962978", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075180777", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-06", 
    "datePublishedReg": "2017-06-01", 
    "description": "BACKGROUND AND OBJECTIVES: Roflumilast is a selective, oral phosphodiesterase 4 inhibitor approved for the treatment of severe chronic obstructive pulmonary disease. The aim of this study was to evaluate the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy Chinese subjects, and the effects of gender and food on their respective pharmacokinetic profiles.\nMETHODS: 36 healthy Chinese subjects were recruited in a randomized, single-center, open-label, parallel group study and assigned to 0.25-, 0.375-, and 0.5-mg dose groups. The single-dose pharmacokinetic studies in fasting condition were carried out in all groups. Moreover, the food effect study and multiple-dose study were conducted in 0.375-mg dose group. Serial blood samples were collected over 168\u00a0h after dosing, and plasma concentrations of roflumilast and roflumilast N-oxide were determined using a validated LC-MS/MS method.\nRESULTS: After oral administration of single doses of 0.25, 0.375 and 0.5\u00a0mg of roflumilast under fasting condition, the mean AUC0-72h for roflumilast was 21.7\u00a0\u00b1\u00a08.3, 29.8\u00a0\u00b1\u00a08.3 and 54.2\u00a0\u00b1\u00a021.3\u00a0ng\u00b7h/mL, respectively. Meanwhile the mean AUC0-168h for roflumilast N-oxide was 290\u00a0\u00b1\u00a0103, 385\u00a0\u00b1\u00a0107 and 673\u00a0\u00b1\u00a0245\u00a0ng\u00b7h/mL, respectively. In the steady state after the multi-dose administration, the exposure to roflumilast in the subjects increased 20-40\u00a0%, and the exposure to roflumilast N-oxide increased about 169\u00a0%, compared to the single-dose administration. No statistically significant effect of gender on the disposition of roflumilast and roflumilast N-oxide was observed. Food had no effect on systemic exposure to roflumilast and roflumilast N-oxide in the subjects, but delayed the T max of roflumilast by 0.9\u00a0h and reduced the C max of roflumilast by approximately 20\u00a0%.\nCONCLUSION: Based upon between-study comparison, peak and systemic exposure of roflumilast and roflumilast N-oxide were higher in Chinese than that in Caucasian subjects after oral administration of the same dose (i.e., 0.25 and 0.5\u00a0mg). It implies that the therapeutic dose for Chinese patients may be different from that for Caucasians, warranting further investigation.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s13318-016-0343-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085481", 
        "issn": [
          "0378-7966", 
          "2107-0180"
        ], 
        "name": "European Journal of Drug Metabolism and Pharmacokinetics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "42"
      }
    ], 
    "name": "Pharmacokinetics of Roflumilast and Its Active Metabolite Roflumilast N-Oxide in Healthy Chinese Subjects After Single and Multiple Oral Doses", 
    "pagination": "371-381", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6168e4cc570b3af01297018735d60bdefbbebd5558b2fbae5ca4ffbba75c147e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27306372"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7608491"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13318-016-0343-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1020443704"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13318-016-0343-4", 
      "https://app.dimensions.ai/details/publication/pub.1020443704"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000362_0000000362/records_87115_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs13318-016-0343-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13318-016-0343-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13318-016-0343-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13318-016-0343-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13318-016-0343-4'


 

This table displays all metadata directly associated to this object as RDF triples.

239 TRIPLES      21 PREDICATES      68 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13318-016-0343-4 schema:about N0bbd68bd538a49d6bb24b273f105e6ad
2 N1e34bbbe9d6b45f99017b20287b6fb80
3 N1f823022218a4828899ee28297664d88
4 N21f3e3cfad7d4680aebb4a9612cc76f4
5 N32e2dfebf8e24b198b34f3634c6b6841
6 N3745a2f0005d49a38a7f9ffac2015bfc
7 N45ec4f96b5ad45ffa222b345faa39136
8 N55c966f051b64339962def14c6227384
9 N79c44c909888475a8cb736c29920c504
10 N7ee2109501da4dfba00ffbbd1e814acd
11 N84a5a9236ae14bd58083aa68e1d46bb1
12 N8f80cb1adbf34854901f3d7ee3f24c8b
13 N93068792b4fe47c1932299f91765e3ff
14 N9bfac459068a416db54cf7ff2f99222e
15 Ne06cebc5311e43cdb798a529808588fd
16 Nf806553c9aff4464951d426c9cc48345
17 anzsrc-for:11
18 anzsrc-for:1115
19 schema:author Nbec32b086b174bc98d143cc34a6645be
20 schema:citation sg:pub.10.1007/bf00216063
21 sg:pub.10.1007/s40262-013-0089-y
22 sg:pub.10.1067/mcp.2001.115447
23 sg:pub.10.1067/mcp.2001.117703
24 sg:pub.10.2165/00003088-200746050-00003
25 sg:pub.10.2165/00003088-200746070-00006
26 sg:pub.10.2165/11536600-000000000-00000
27 https://app.dimensions.ai/details/publication/pub.1074786415
28 https://app.dimensions.ai/details/publication/pub.1074786416
29 https://app.dimensions.ai/details/publication/pub.1074962978
30 https://app.dimensions.ai/details/publication/pub.1075180777
31 https://doi.org/10.1016/j.pupt.2010.03.011
32 https://doi.org/10.1046/j.1365-2710.2000.00281.x
33 https://doi.org/10.1055/s-0042-121903
34 https://doi.org/10.1111/j.1365-2125.2011.04076.x
35 https://doi.org/10.1111/j.1476-5381.2011.01218.x
36 https://doi.org/10.1164/rccm.200612-1749oc
37 https://doi.org/10.1177/0091270004268128
38 https://doi.org/10.1177/0091270006294529
39 https://doi.org/10.1378/chest.07-1131
40 https://doi.org/10.1378/chest.13-1252
41 https://doi.org/10.3389/fphys.2015.00294
42 https://doi.org/10.5414/cp201556
43 schema:datePublished 2017-06
44 schema:datePublishedReg 2017-06-01
45 schema:description BACKGROUND AND OBJECTIVES: Roflumilast is a selective, oral phosphodiesterase 4 inhibitor approved for the treatment of severe chronic obstructive pulmonary disease. The aim of this study was to evaluate the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy Chinese subjects, and the effects of gender and food on their respective pharmacokinetic profiles. METHODS: 36 healthy Chinese subjects were recruited in a randomized, single-center, open-label, parallel group study and assigned to 0.25-, 0.375-, and 0.5-mg dose groups. The single-dose pharmacokinetic studies in fasting condition were carried out in all groups. Moreover, the food effect study and multiple-dose study were conducted in 0.375-mg dose group. Serial blood samples were collected over 168 h after dosing, and plasma concentrations of roflumilast and roflumilast N-oxide were determined using a validated LC-MS/MS method. RESULTS: After oral administration of single doses of 0.25, 0.375 and 0.5 mg of roflumilast under fasting condition, the mean AUC0-72h for roflumilast was 21.7 ± 8.3, 29.8 ± 8.3 and 54.2 ± 21.3 ng·h/mL, respectively. Meanwhile the mean AUC0-168h for roflumilast N-oxide was 290 ± 103, 385 ± 107 and 673 ± 245 ng·h/mL, respectively. In the steady state after the multi-dose administration, the exposure to roflumilast in the subjects increased 20-40 %, and the exposure to roflumilast N-oxide increased about 169 %, compared to the single-dose administration. No statistically significant effect of gender on the disposition of roflumilast and roflumilast N-oxide was observed. Food had no effect on systemic exposure to roflumilast and roflumilast N-oxide in the subjects, but delayed the T max of roflumilast by 0.9 h and reduced the C max of roflumilast by approximately 20 %. CONCLUSION: Based upon between-study comparison, peak and systemic exposure of roflumilast and roflumilast N-oxide were higher in Chinese than that in Caucasian subjects after oral administration of the same dose (i.e., 0.25 and 0.5 mg). It implies that the therapeutic dose for Chinese patients may be different from that for Caucasians, warranting further investigation.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree false
49 schema:isPartOf Ndf0c4ea2b5d345aeaab61b1ce127f21b
50 Ne7eaf5d971714a5aaff47562e3f929e0
51 sg:journal.1085481
52 schema:name Pharmacokinetics of Roflumilast and Its Active Metabolite Roflumilast N-Oxide in Healthy Chinese Subjects After Single and Multiple Oral Doses
53 schema:pagination 371-381
54 schema:productId N49d7246f6b9d4740b4c3cbe8db9ed29a
55 N8647c0811d25468c8b1e748819b16dbe
56 N8eb51d2329bb4b5fa3cc03adba234c12
57 N9ae9f42b74f24fcd93deba0cdb884951
58 Ne120a152d77e418f957505f12b42af79
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020443704
60 https://doi.org/10.1007/s13318-016-0343-4
61 schema:sdDatePublished 2019-04-11T12:26
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher Nde1d561840ba44b4afeb6861f84235a0
64 schema:url https://link.springer.com/10.1007%2Fs13318-016-0343-4
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N0bbd68bd538a49d6bb24b273f105e6ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Area Under Curve
70 rdf:type schema:DefinedTerm
71 N1e34bbbe9d6b45f99017b20287b6fb80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Dose-Response Relationship, Drug
73 rdf:type schema:DefinedTerm
74 N1f823022218a4828899ee28297664d88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Healthy Volunteers
76 rdf:type schema:DefinedTerm
77 N21f3e3cfad7d4680aebb4a9612cc76f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Cyclopropanes
79 rdf:type schema:DefinedTerm
80 N32e2dfebf8e24b198b34f3634c6b6841 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Humans
82 rdf:type schema:DefinedTerm
83 N3745a2f0005d49a38a7f9ffac2015bfc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Female
85 rdf:type schema:DefinedTerm
86 N45ec4f96b5ad45ffa222b345faa39136 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Tandem Mass Spectrometry
88 rdf:type schema:DefinedTerm
89 N470e0481fd0147359cd4bf91b49e120a rdf:first sg:person.01353315753.29
90 rdf:rest N505bc2ddfdb341a796c816281acd445a
91 N49d7246f6b9d4740b4c3cbe8db9ed29a schema:name readcube_id
92 schema:value 6168e4cc570b3af01297018735d60bdefbbebd5558b2fbae5ca4ffbba75c147e
93 rdf:type schema:PropertyValue
94 N4efec8b53e074830b8bd385c4eca5a48 schema:name Nanjing Clinical Tech Laboratories Inc., 18 Zhilan Road, Jiangning District, 211000, Nanjing, People’s Republic of China
95 rdf:type schema:Organization
96 N505bc2ddfdb341a796c816281acd445a rdf:first sg:person.0627711653.12
97 rdf:rest rdf:nil
98 N55c966f051b64339962def14c6227384 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Chromatography, Liquid
100 rdf:type schema:DefinedTerm
101 N79c44c909888475a8cb736c29920c504 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Adult
103 rdf:type schema:DefinedTerm
104 N7ee2109501da4dfba00ffbbd1e814acd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Young Adult
106 rdf:type schema:DefinedTerm
107 N84a5a9236ae14bd58083aa68e1d46bb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Administration, Oral
109 rdf:type schema:DefinedTerm
110 N8647c0811d25468c8b1e748819b16dbe schema:name dimensions_id
111 schema:value pub.1020443704
112 rdf:type schema:PropertyValue
113 N8eb51d2329bb4b5fa3cc03adba234c12 schema:name doi
114 schema:value 10.1007/s13318-016-0343-4
115 rdf:type schema:PropertyValue
116 N8f80cb1adbf34854901f3d7ee3f24c8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Phosphodiesterase Inhibitors
118 rdf:type schema:DefinedTerm
119 N93068792b4fe47c1932299f91765e3ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Aminopyridines
121 rdf:type schema:DefinedTerm
122 N9ae9f42b74f24fcd93deba0cdb884951 schema:name pubmed_id
123 schema:value 27306372
124 rdf:type schema:PropertyValue
125 N9bfac459068a416db54cf7ff2f99222e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Asian Continental Ancestry Group
127 rdf:type schema:DefinedTerm
128 N9f2e95b39cd34643b68b9613b947c664 rdf:first sg:person.01140701426.68
129 rdf:rest N470e0481fd0147359cd4bf91b49e120a
130 Nbec32b086b174bc98d143cc34a6645be rdf:first sg:person.0740757371.86
131 rdf:rest Nd977f851e2a54eb5a29f2fd92d5ad7cb
132 Nd977f851e2a54eb5a29f2fd92d5ad7cb rdf:first sg:person.015572713305.52
133 rdf:rest N9f2e95b39cd34643b68b9613b947c664
134 Nde1d561840ba44b4afeb6861f84235a0 schema:name Springer Nature - SN SciGraph project
135 rdf:type schema:Organization
136 Ndf0c4ea2b5d345aeaab61b1ce127f21b schema:issueNumber 3
137 rdf:type schema:PublicationIssue
138 Ne06cebc5311e43cdb798a529808588fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Male
140 rdf:type schema:DefinedTerm
141 Ne120a152d77e418f957505f12b42af79 schema:name nlm_unique_id
142 schema:value 7608491
143 rdf:type schema:PropertyValue
144 Ne7eaf5d971714a5aaff47562e3f929e0 schema:volumeNumber 42
145 rdf:type schema:PublicationVolume
146 Nf806553c9aff4464951d426c9cc48345 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Benzamides
148 rdf:type schema:DefinedTerm
149 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
150 schema:name Medical and Health Sciences
151 rdf:type schema:DefinedTerm
152 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
153 schema:name Pharmacology and Pharmaceutical Sciences
154 rdf:type schema:DefinedTerm
155 sg:journal.1085481 schema:issn 0378-7966
156 2107-0180
157 schema:name European Journal of Drug Metabolism and Pharmacokinetics
158 rdf:type schema:Periodical
159 sg:person.01140701426.68 schema:affiliation https://www.grid.ac/institutes/grid.254147.1
160 schema:familyName Liu
161 schema:givenName Lingye
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140701426.68
163 rdf:type schema:Person
164 sg:person.01353315753.29 schema:affiliation https://www.grid.ac/institutes/grid.477246.4
165 schema:familyName Ma
166 schema:givenName Pengcheng
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353315753.29
168 rdf:type schema:Person
169 sg:person.015572713305.52 schema:affiliation N4efec8b53e074830b8bd385c4eca5a48
170 schema:familyName Wang
171 schema:givenName Yiya
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015572713305.52
173 rdf:type schema:Person
174 sg:person.0627711653.12 schema:affiliation https://www.grid.ac/institutes/grid.254147.1
175 schema:familyName Ding
176 schema:givenName Li
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627711653.12
178 rdf:type schema:Person
179 sg:person.0740757371.86 schema:affiliation https://www.grid.ac/institutes/grid.254147.1
180 schema:familyName Li
181 schema:givenName Qian
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740757371.86
183 rdf:type schema:Person
184 sg:pub.10.1007/bf00216063 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030399080
185 https://doi.org/10.1007/bf00216063
186 rdf:type schema:CreativeWork
187 sg:pub.10.1007/s40262-013-0089-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1051435708
188 https://doi.org/10.1007/s40262-013-0089-y
189 rdf:type schema:CreativeWork
190 sg:pub.10.1067/mcp.2001.115447 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001959141
191 https://doi.org/10.1067/mcp.2001.115447
192 rdf:type schema:CreativeWork
193 sg:pub.10.1067/mcp.2001.117703 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003973100
194 https://doi.org/10.1067/mcp.2001.117703
195 rdf:type schema:CreativeWork
196 sg:pub.10.2165/00003088-200746050-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042151859
197 https://doi.org/10.2165/00003088-200746050-00003
198 rdf:type schema:CreativeWork
199 sg:pub.10.2165/00003088-200746070-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048498102
200 https://doi.org/10.2165/00003088-200746070-00006
201 rdf:type schema:CreativeWork
202 sg:pub.10.2165/11536600-000000000-00000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044802363
203 https://doi.org/10.2165/11536600-000000000-00000
204 rdf:type schema:CreativeWork
205 https://app.dimensions.ai/details/publication/pub.1074786415 schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1074786416 schema:CreativeWork
207 https://app.dimensions.ai/details/publication/pub.1074962978 schema:CreativeWork
208 https://app.dimensions.ai/details/publication/pub.1075180777 schema:CreativeWork
209 https://doi.org/10.1016/j.pupt.2010.03.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050658534
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1046/j.1365-2710.2000.00281.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1047972899
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1055/s-0042-121903 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074194059
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1111/j.1365-2125.2011.04076.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039517595
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1111/j.1476-5381.2011.01218.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1025189857
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1164/rccm.200612-1749oc schema:sameAs https://app.dimensions.ai/details/publication/pub.1000450293
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1177/0091270004268128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051961362
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1177/0091270006294529 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035843651
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1378/chest.07-1131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003811806
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1378/chest.13-1252 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006208929
228 rdf:type schema:CreativeWork
229 https://doi.org/10.3389/fphys.2015.00294 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038971699
230 rdf:type schema:CreativeWork
231 https://doi.org/10.5414/cp201556 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072834043
232 rdf:type schema:CreativeWork
233 https://www.grid.ac/institutes/grid.254147.1 schema:alternateName China Pharmaceutical University
234 schema:name Department of Pharmaceutical Analysis, China Pharmaceutical University, 24 Tongjiaxiang, 210009, Nanjing, People’s Republic of China
235 Nanjing Clinical Tech Laboratories Inc., 18 Zhilan Road, Jiangning District, 211000, Nanjing, People’s Republic of China
236 rdf:type schema:Organization
237 https://www.grid.ac/institutes/grid.477246.4 schema:alternateName Chinese Academy of Medical Sciences Dermatology Hospital
238 schema:name Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, 12 Jiangwangmiao Street, 210042, Nanjing, People’s Republic of China
239 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...